Your browser doesn't support javascript.
loading
Pharmacokinetics and safety of a single dose of the novel necrosis inhibitor LC28-0126 in healthy male subjects.
Kim, Seokuee; Chung, Hyewon; Lee, SeungHwan; Cho, Sang-Heon; Cho, Hyun-Jai; Kim, Soon Ha; Jang, In-Jin; Yu, Kyung-Sang.
Afiliação
  • Kim S; Department of Clinical Pharmacology and Therapeutics, Seoul National University College of Medicine and Hospital, Seoul, South Korea.
  • Chung H; Department of Clinical Pharmacology and Therapeutics, Seoul National University College of Medicine and Hospital, Seoul, South Korea.
  • Lee S; Department of Clinical Pharmacology and Therapeutics, Seoul National University College of Medicine and Hospital, Seoul, South Korea.
  • Cho SH; Department of Clinical Pharmacology, Inha University School of Medicine and Hospital, Incheon, South Korea.
  • Cho HJ; Division of Cardiology, Department of Internal Medicine, Seoul National University College of Medicine and Hospital, Seoul, South Korea.
  • Kim SH; R&D Park, LG Life Sciences Ltd, Daejeon, South Korea.
  • Jang IJ; Department of Clinical Pharmacology and Therapeutics, Seoul National University College of Medicine and Hospital, Seoul, South Korea.
  • Yu KS; Department of Clinical Pharmacology and Therapeutics, Seoul National University College of Medicine and Hospital, Seoul, South Korea.
Br J Clin Pharmacol ; 83(6): 1205-1215, 2017 06.
Article em En | MEDLINE | ID: mdl-28002882

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Necrose Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adult / Humans / Male / Middle aged Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Necrose Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adult / Humans / Male / Middle aged Idioma: En Ano de publicação: 2017 Tipo de documento: Article